DCF — BAPTIST MEDICAL CENTER
Enterprise Value: $-197.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-197.0M
Enterprise Value
$-108.1M
PV of Cash Flows
$-88.9M
PV of Terminal Value
$-143.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.8B | $25.4M | 1.0% | $-52.3M | $-47.5M |
| Year 2 | $1.9B | $45.1M | 2.0% | $-34.9M | $-28.9M |
| Year 3 | $1.9B | $65.9M | 3.0% | $-20.8M | $-15.6M |
| Year 4 | $2.0B | $77.9M | 4.0% | $-13.9M | $-9.5M |
| Year 5 | $2.1B | $85.4M | 4.0% | $-10.5M | $-6.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-197.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.8B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.008844391607402698
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5